April 2022 Bloodbath - Names Down >30% Since April 1
April 2022 was one of the worst market months of all time. In fact, it was the worst since October 2008. Here are 100 stocks down >30% since April 1:


Visit highsandlows.substack.com
post mediapost media
Round Trips
There have been a ton of major "round trips" since 2020. These are names that soared higher in 2020 and have come all the way back . Here are a bunch in no particular order:

EDIT: I am calling these the Covid-180's

$FB - Meta Platforms, Inc. - Internet Content & Information - $534.71B

$NFLX - Netflix, Inc. - Entertainment - $92.44B

$SHOP - Shopify Inc. - Software - Application - $61.52B

$SE - Sea Limited - Electronic Gaming & Multimedia - $53.12B

$U - Unity Software Inc. - Software - Application - $24.17B

$SPOT - Spotify Technology S.A. - Internet Content & Information - $23.55B

$RBLX - Roblox Corporation - Electronic Gaming & Multimedia - $19.97B

$CHWY - Chewy, Inc. - Internet Retail - $15.12B

$ROKU - Roku, Inc. - Entertainment - $14.01B

$PINS - Pinterest, Inc. - Internet Content & Information - $13.67B

$CVNA - Carvana Co. - Internet Retail - $13.47B

$PTON - Peloton Interactive, Inc. - Leisure - $6.73B

$MRTX - Mirati Therapeutics, Inc. - Biotechnology - $4.01B

$INMD - InMode Ltd. - Medical Devices - $2.55B

$FVRR - Fiverr International Ltd. - Internet Retail - $2.10B

$CDLX - Cardlytics, Inc. - Internet Content & Information - $1.47B

$NEO - NeoGenomics, Inc. - Diagnostics & Research - $1.41B

$NVTA - Invitae Corporation - Diagnostics & Research - $1.29B

$TREE - LendingTree, Inc. - Mortgage Finance - $1.28B

$SNBR - Sleep Number Corporation - Furnishings, Fixtures & Appliances - $1.11B

$TTCF - Tattooed Chef, Inc. - Packaged Foods - $737.26M
post mediapost media
Mega week for earnings! (Nov 8-12)
Here are featured earnings we are paying attention to @ Fincredible.

The ones I'm paying close attention are:

$PYPL - Want to learn more about their plans for 'super app', integration of BNPL and if any color on rumored $PINS acqn, which is now dead (or never was there). I own some $PYPL

$PLTR - I think I'm the only non-bull on this company. I'm unsure of their technological prowess and confused by their corporate governance. I don't own and have no plans, but just curious.

$COIN - I have no exposure in crypto except via a managed investment on Titan, but I think this is a great way to continue to learn and try and get smarter

$U - I like this company a lot. I'm particularly interested in their non-gaming revenues which I think is a larger TAM. Selfishly, I'm hoping this stock falls after earnings (Sorry for the many who own it) so I can buy on the dip, but not expecting it.

$SOFI $AFRM - I view both of these innovative companies but are overpriced, and don't have as much moat as people give them credit. Yet always interested to hear about them to be proven wrong, and given my investments in $PYPL, banks, and various private fintechs

$EHTH - not Ethereum, but eHealth. Given they fired most of the management team recently, always interested in what the tone/focus of the call is.

BTW as of this week, for S&P 500 companies (plus other popular stocks) you can not only play the calls in real-time at Fincredible, but also read the transcript and monitor specific keywords in real-time. Check it out - https://app.fincredible.ai/latest-earnings

MON

TUE

WED

THU

post media
Colin's avatar
$72m follower assets
With so much on sale it’s like Black Friday around here...
How many others like me are wishing they had more dry powder to plow into the recent pull backs in 2020s high fliers?

Today I made some modest buys of some stocks that should outperform over the next decade and will continue building my position dollar cost averaging from here.

$HOL (Astra) is a new #space play for getting satellites into lower earth orbit. Today the price plunged closer to its starting reverse merger spac $10 origin. I’m inspired by the work SpaceX is doing with Starlink low earth orbit arrays and excited to invest in this “space” #longterm #hodl

$NVTA (invitae) is like 23andMe if the #DNA results were applied to personalized healthcare and medication. Instead of a one size fits all approach to healthcare this strategy seeks to match you based on your genes to the right form of treatment. A silver lining to covid and the MRNA vaccines has accelerated the pace and acceptance of this form of medicine. #longterm #hodl

$ABNB (Airbnb) is a sleeping giant if you ask me. It’s IPO happened during the darkest time in the companies history, think of that. This is a special company with the right mix of leadership, brand awareness, technology and TAM. I can’t wait to take several trips once most are vaccinated and I know many others who feel the same way. The recent pullback from Airbnb highs make this a no brained heading into the #Roaring2020s .

Where’s your dry powder heading this week?
A Crack In Creation: Chapter 1 (part 1)
I'm currently reading "A Crack in Creation" by Jennifer Doudna in order to deepen my knowledge of the gene editing space.

There's a 'Genomics Revolution' channel on Commonstock if you want to join: https://share.commonstock.com/share?invite=RqCajG

Chapter 1 - Cliff Notes
Here's an example of the power and promise of gene editing:

In 2013, scientists at the National Institutes of Health were dealing with a medical mystery. A patient we'll call Kim had a rare, painful, and potentially deadly immunodeficiency disease called WHIM syndrome. WHIM is caused by a tiny mutation- a single incorrect letter among some six billion total letters of one's DNA. This tiny transformation leaves victims profoundly susceptible to infection to human papillomavirus (HPV), which causes uncontrollable warts that cover the patient's skin and can eventually progress to cancer.

Early in life Kim had been diagnosed with this disorder, yet 50 years later, it seemed to have miraculously vanished from her system. How was this possible?

After a battery of tests, the scientists concluded that Kim experienced an uncommon and usually catastrophic event called chromothripsis- a phenomenon in which a chromosome suddenly shatters and then is repaired, leading to a massive rearrangement of the genes within it. The effects in the body are generally either trivial (if the damaged cell dies immediately) or dire (if the rearranged DNA inadvertently activates cancer-causing genes)

In Kim's body, though, chromothripsis allowed her mutated cell to be free of the gene causing WHIM syndrome. And that cell happened to also be a hematopoietic stem cell, a type of stem cell from which every kind of blood cell in the body originates and that has an almost unlimited potential to proliferate and self-renew. That cell had passed along its rearranged chromosome to all its daughter cells, eventually repopulating Kim's entire immune system with healthy new white blood cells that were free of the mutation.

The odds of being spontaneously cured of a genetic disease are miniscule. Most patients will never experience the natural miracle of having their genomes altered in exactly the right way, in the right kinds of cells, and in the right tissues. Natural gene editing remains an anomaly - some interesting medical cases involving a handful of patients who won the genetic lottery, nothing more.

But what if gene editing weren't only a spontaneous event? What if doctors had a way to fix harmful mutations?

To make this sort of technology possible, you need to understand the genome itself: what it is made of, how it was built, and most important, how it can be modified and manipulated.

The Genome
The genome refers to the entire set of genetic instructions found inside a cell. Mostly identical from cell to cell within any given organism save for the occasional mutation, the genome tells all living things how to grow, how to sustain themselves, and how to transmit genes to offspring.

Our intrinsic physical traits - eyesight, height, skin color, predisposition to disease, and so on- are the result of information encoded in our genomes.

The genome is made up of a molecule called deoxyribonucleic acid, or DNA, which is constructed of just four different building blocks. Known as nucleotides, these are the familiar letters of DNA: A, G, C, and T, shorthand for the chemical groups (also known as bases) of adenine, guanine, cytosine, and thymine that distinguish the four compounds. The letters of these molecules are connected in long single strands. Two of these strands come together to form the famous double-helix structure of DNA.

DNA is much like a secret language; each specific sequence of letters provides instructions to produce a particular protein inside the cell. The proteins then go on to carry out most of the critical functions in the body, like breaking down food, recognizing and destroying pathogens, and sensing light.

We know the genetic causes of many diseases thanks to the relatively recent advent of DNA sequencing, a process that enables scientists to read and record the contents of the human genome, letter by letter. Scientists have precisely identified well over four thousand different kinds of DNA mutations that can cause genetic disease.

DNA sequencing can tell individuals if they're at elevated risk of developing certain cancers, and it can help tailor specific treatments to best match the genetic backgrounds of different patients.

Furthermore, now that commercial DNA sequence analysis has gone mainstream and costs just a few hundred dollars per test (think $NVTA) , millions of individuals have opted to have their own genomes analyzed by simply dropping a saliva sample in the mail. The resulting explosion of data has helped researchers pinpoint significant associations between thousands of gene variants and a number of physical and behavioral traits.

Yet, while genome sequencing represents a huge development in the study of genetic disease, it is ultimately a diagnostic tool, not a form of treatment. It has allowed us to see how genetic diseases are written in the language of DNA, but it leaves us powerless to change that language. After all, it's one thing to learn how to read; it's quite another to learn how to write. For that, scientists need an entirely different set of tools.

post mediapost media
This is awesome thanks for sharing! I have this book on my bookshelf and have been meaning to get to it. But if you're gonna post the cliff notes, I might not have to. High school all over again!
View 15 more comments
Elise's avatar
$7.6m follower assets
Today’s Moves
Oy! A more eventful morning than I would have liked! All vaccine related.

Sold $BNTX today. Probably should have sold sooner but was remaining hopeful all week. Going to continue to watch it and consider getting back in at $100.

Honestly could say the exact same thing about $CVAC. Sold but will still have an alert on $100. Their results of their Phase 3 aren’t looking great so a bit less interested in this one.

Took sizable profits on both but could have taken more if I had pulled the plug a few days ago 🙃 Don’t you love when that happens?

Continuing to hold $NVAX and $NVTA probably despite my best judgement. Put some serious alerts on though so I don’t miss anything.

In news outside bio, added to $OKTA and $TWLO positions.
I really like Invitae $NVTA for the long term even though it is a risky play for world domination they're shooting for.

For me its a 'size according to how much I'm willing to lose' and then just don't sell. Otherwise I'll be a weak hand with all the volatility. In my opinion this is a company where Morgan Housel's words ring true: "Volatility is a admission fee worth paying"
View 1 more comment
Sold all of my $WORK shares
Why?

I like Salesforce a lot.

I like the leadership, vision and execution.

However:

  • I get the sense that as the business has scaled they have run into trouble when attempting to build new products in house that expand the TAM and provide additional optionality. This belief is reinforced by the Mulesoft, Tableau and Slack acquisitions.


  • The road ahead is in direct competition with $MSFT. Granted, this was also the case when $WORK was independent. However, now this new organization will be competing against Satya Nadella's behemoth across many different dimensions but without the vertical integration (hardware & software) that powers $MSFT's business.


  • Salesforce will also likely need to eventually compete in the public cloud infrastructure game against AWS, Azure & GCP. I could see another acquisition down the road of a company like Digital Ocean. Each new acquisition and corresponding new business vector introduces a new risk to the companies culture and execution.

In general, I cringe at the idea of selling shares but I think I'm at peace with the possibility of $CRM becoming a multi-trillion dollar company from here and me not owning a piece of it.

In my view, $CRM can definitely 10x from here but it will likely be a bloody battle over a potentially very long period of time where they had to move heaven and earth. As an investor, I prefer to minimize my exposure to investments where I expect the company to move heaven and earth in order to deliver good returns. $AMZN & $NVDA are currently those workhorses for me and account for ~20% of my portfolio. While he's been phenomenally successful, I'm not sure that I'd put Benioff in the same category as Bezos and Jensen.

Part of the problem for me with this acquisition was that:


  • The terms of the deal were half cash/half stock. The cash portion becomes a taxable event in 2021 and then I'd have to actively choose to purchase more $CRM over other positions. Hard for me to justify that.


  • I have other ideas that I feel I am under invested in. This list includes: $SQ $TWLO $OKTA $PD $SFIX $NVTA and $NVDA. (fwiw I like $NVDA much more than $CRM although they are very different companies).

I'll be holding the proceeds from $WORK in my savings account for now but I'm weighing a few options as far as what to eventually do with the proceeds:


  • Dollar cost average into a basket of my large cap stocks: $TWLO $OKTA and/or $NVDA.


  • Dollar cost average into a basket of my mid cap stocks: $PD $SFIX $NVTA.


  • Dollar cost average all proceeds into $SQ.

Ultimately, I think a logical decision here would be to allocate these proceeds to a similar risk/reward profile as $WORK prior to the $CRM acquisition. At the moment, this feels like $TWLO $OKTA and maybe $NVDA .

Any feedback or questions on this thought process would be appreciated!
One thing is sure; no one does CRM better than $CRM (you see what I did there :D)

On a serious note, they've struggled with bloated UI/UX for years but have a cult following among the sales leaders and C-level executives. As anyone scales; salesforce becomes a de facto choice. Dynamics is way behind.

I did buying for Srijan for very long and spend 2 years researching a good PSA solution; honestly there was none in market which came close to FinancialForce and their subscription started 100k USD. We ended up becoming a customer as the problem we were solving was worth millions.

That's why I am $CRM a 7% holding stock! I am not bullish on it like $AMZN or $TWLO for sure; but it's a safe stock to hold for long.
View 3 more comments
ztinvesting's avatar
$91.1m follower assets
10 Trends for the 2020s
Hello everyone!
I am very excited to be a part of this platform and am very grateful to @mcd for all of the hard work he has put in developing this incredible platform. I have just started exploring all that Commonstock has to offer, and I am looking forward to being along for the ride as this platform grows.
A bit about my investing strategy: I am a young investor with a long-term, buy-and-hold outlook. I am looking for innovative, disruptive companies with mass appeal to younger generations and huge growth potential. Overall, my portfolio is molded around two main ideas, both taken from the great David Gardner:
  • "Make your portfolio reflect your best vision for the future." I invest in companies that I believe are pushing the world forward in a meaningful, inclusive, and sustainable fashion. When a company falls out of line with my best vision for the future, I put my money elsewhere.
  • "Find out where the world is going - and get there as soon as possible." Between my life experiences, reading, research, and conversations, I have attempted to continuously shape my understanding of where the world is going. As I find trends that I believe reflect the future of our society, I search for companies capitalizing on those trends and invest in those that I find to be exciting.
Those trends are the subject of this post. See below for my thoughts on ten exciting trends that I believe will come to define the 2020s, as well as some of my top investment ideas for each!
'
1. E-Commerce - As society becomes more and more interconnected and focused on convenience, e-commerce is a trend that is poised to thrive. We have already seen the potential that e-commerce can have with $AMZN, but there is plenty of exciting potential elsewhere as well. Over the next decade, I expect e-commerce to thrive globally. Top Ideas: $AMZN, $SHOP, $MELI, $SE . . .
'
2. Financial Technology - Young people are increasingly distrustful of banks and increasingly excited by technology-based companies that help manage and improve financial outcomes. At the same time, banks have historically left out significant portions of the population and have lost the faith of the people in countries across the world (Brazil, etc.). Some very exciting companies have emerged to fill this void, and I expect great results from them over the long-term. Top Ideas: $SQ, $PYPL, $MA, $STNE . . .
'
3. Software-as-a-Service (SaaS) - Over the last few years, a plethora of high-growth, exciting software companies have emerged. These companies offer cutting-edge services that save others time and money, while making business operations faster, more efficient, and more valuable. All SaaS companies will definitely not be successful, but the best of them have huge runways for growth. Top Ideas: $CRWD, $DOCU, $DDOG, $TWLO . . .
'
4. Advanced Technology - As society advances, people's technological needs become more specified and more advanced. While this shift has left some historical winners behind, it has accelerated the growth of a handful of exciting advanced tech. companies. Top Ideas: $NVDA, $AAPL, $GOOG, $MSFT . . .
'
5. Clean Energy - With climate change as a prominent issue, society is making a massive shift towards clean energy sources. Alternative energy sources such as solar and nuclear power are gaining more and more traction, while electric vehicles are captivating drivers across the globe. This is a young, crowded space, but some leaders are certainly emerging in this high-growth industry. Top Ideas; $TSLA, $MP, $SEDG, $ENPH . . .
'
6. Healthcare - The healthcare industry is outdated, inaccessible, and undesirable to patients throughout the world. Between costly insurance plans, outdated technologies, and absurd prices, there is plenty of room for disruption. In the last few years, dozens of thrilling companies have emerged to fill these voids, and offer promising returns to shareholders over the next decade. Top Ideas: $TDOC, $NNOX, $ISRG, $TMDX . . .
'
7. Remote Lifestyle - Coupled with the interconnectivity that has been brought about by globalization, the COVID-19 pandemic has accelerated a societal shift to a more remote lifestyle. This does not necessarily mean work from home, but rather an overall trend in which people across the globe can access essential services, conduct international meetings, and hire global talent from the comfort of their own home. Not all pandemic winners will thrive over the next decade, but some certainly will. Top Ideas: $ZM, $FVRR, $PTON, $WORK . . .
'
8. Real Estate - In the United States specifically, the real estate industry is outdated, inefficient, and complicated. In recent years, a couple of innovative companies have debuted compelling alternatives to the traditional real estate system. In such a large industry, these companies offer investors a unique opportunity to invest in high-growth, easily understandable companies with a massive TAM. Top Ideas: $RDFN, $Z, $IPOB . . .
'
9. Genomic Revolution - Gene editing companies have burst onto the scene over the last few years, promising revolutionary cures to complicated diseases and a massive shift in global medicine. An investment in these companies is highly speculative, but there are some incredible companies with the potential for huge returns in this industry. Top Ideas: $ARKG, $NVTA, $CRSP, $EDIT . . .
'
10. Online Gambling - Online gambling, and particularly sports gambling, is a quickly growing market in the U.S. and globally that offers potentially huge returns for investors. There are some regulatory hurdles to clear, but I believe that those hurdles will be cleared over the next decade and that some big winners will emerge in this industry. Top Ideas: $DKNG, $PENN . .
'
Thank you so much for reading this post! I would love to hear anyone's thoughts or comments on these trends or additional companies/trends that you believe will thrive over the next decade. I will be posting more thoughts on this platform over time, and I also post additional ideas on my twitter @ztinvesting!
Love this memo! I agree with much of what you wrote. I haven't looked into online gambling or genomics as much as I should. $SGEN has been one of my best investments. $TRUP has also been great this year for me. Really excited about healthcare tech. Or just anything that's going tech.
View 3 more comments
Commonstock is a social network that amplifies the knowledge of the best investors, verified by actual track records for signal over noise. Community members can link their existing brokerage accounts and share their real time portfolio, performance and trades (by percent only, dollar amounts never shared). Commonstock is not a brokerage, but a social layer on top of existing brokerages helping to create more engaged and informed investors.